Monthly diagnostic testing.

Ended Awarded Last action

Contract number
HT009026FH014
Awardee
Awarding agency
Obligated
$38,337

Award facts

Contract value 100% obligated
$38,337.35 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Health Agency issued a BPA call to Ortho-Clinical Diagnostics, Inc. for monthly diagnostic testing with a ceiling value of $38,337.35 and an award date of May 5, 2026. The call is for firm fixed-price monthly diagnostic testing services to be performed in Raritan, New Jersey, with an ultimate completion date of September 30, 2026. Ortho-Clinical Diagnostics is a HUBZone joint venture manufacturer of diagnostic laboratory equipment and consumables. The source does not identify the parent BPA name or contracting organization for this call.

Quick answers

Who was awarded contract HT009026FH014?

HT009026FH014 was awarded to Ortho-Clinical Diagnostics, Inc. by Defense Health Agency (Department of Defense) on May 5, 2026.

How much is contract HT009026FH014 worth?

The government has obligated $38,337 on HT009026FH014.

Is contract HT009026FH014 an order under another contract?

Yes. HT009026FH014 is a BPA call under FA860122A0002, a blanket purchase agreement.

Was contract HT009026FH014 competed?

The extent of competition for HT009026FH014 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login